Dr Cody L Wolf, PhD is an expert in Oncology at UPMC Presbyterian (United States). Cody L Wolf has authored 15 publications, the most recent in 2026. SLR score: 58 (community average: 125). How the SLR is computed.

LeadR Profile

Dr Cody L Wolf, PhD UPMC Presbyterian United States
58 ScienceLeadR Reputation 58
Network Map

Oncology

Subspecialties: Immunology - Geriatrics - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2017 - 2026
Source: PubMed

University of Virginia - Postdoctoral Research Associate

2024 - 2026

UPMC Presbyterian

2026 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 15

Citations

Citations: 89 1st author: 8 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Plectin promotes an aggressive phenotype and represses cytotoxic T cell activity in pancreatic cancer.
PMID 42676425 — cells, pancreatic neoplasms, growth, neoplasms, phenotype, immune system diseases, immunity, plectin, therapeutics, t-lymphocytes, tumor microenvironment
Front Immunol20260
Opportunities to enhance cancer research through advocate-researcher partnerships.
PMID 42333993 — neoplasms, research
Cancer Res20260
Plectin promotes an aggressive phenotype and represses cytotoxic T cell activity in pancreatic cancer.
PMID 42079239 — cells, pancreatic neoplasms, growth, neoplasms, phenotype, immunity, plectin, therapeutics, t-lymphocytes, tumor microenvironment
bioRxiv20260
Benefits of Oral Nitrite Supplementation on Mitochondrial Respiration and Physical Function In Older Adults.
PMID 41691463 — muscles, nitrites, respiration, aging, nitrates, muscle, skeletal, blood platelets, geroscience
J Gerontol A Biol Sci Med Sci20260
Development of the First Small-Molecule Inhibitor Targeting Oncostatin M for Treatment of Breast Cancer.
PMID 40747931 — breast neoplasms, oncostatin m, neoplasms, breast, therapeutics, small molecules
J Med Chem20250

LeadR Networks

Main global connection map